Zhao H - Search Results

1

Discovery of Fluorine-Containing Benzoxazinyl-oxazolidinones for the Treatment of Multidrug Resistant Tuberculosis.

Zhao H, Lu Y, Sheng L, Yuan Z, Wang B, Wang W, Li Y, Ma C, Wang X, Zhang D, Huang H. Zhao H, et al. ACS Med Chem Lett. 2017 Apr 12;8(5):533-537. doi: 10.1021/acsmedchemlett.7b00068. eCollection 2017 May 11. ACS Med Chem Lett. 2017. PMID: 28523106 Free PMC article.

2

An improved efficient synthesis of the antibacterial agent torezolid.

Li G, Yuan BK, Tang W, Zhao HY, Lin ZY, Huang HH. Li G, et al. Chem Pharm Bull (Tokyo). 2015;63(2):143-6. doi: 10.1248/cpb.c14-00757. Epub 2014 Dec 10. Chem Pharm Bull (Tokyo). 2015. PMID: 25491645 Free article.

3

An efficient and facile access to highly functionalized pyrrole derivatives.

Gao M, Zhao W, Zhao H, Lin Z, Zhang D, Huang H. Gao M, et al. Among authors: zhao h, zhao w. Beilstein J Org Chem. 2018 Apr 20;14:884-890. doi: 10.3762/bjoc.14.75. eCollection 2018. Beilstein J Org Chem. 2018. PMID: 29765469 Free PMC article.

4

An Efficient Synthesis of Aryl-Substituted Pyrroles by the Suzuki⁻Miyaura Coupling Reaction of SEM-Protected Pyrroles.

Cui K, Gao M, Zhao H, Zhang D, Yan H, Huang H. Cui K, et al. Among authors: zhao h. Molecules. 2019 Apr 22;24(8):1594. doi: 10.3390/molecules24081594. Molecules. 2019. PMID: 31013677 Free PMC article.

5

Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis.

Zhao W, Wang B, Liu Y, Fu L, Sheng L, Zhao H, Lu Y, Zhang D. Zhao W, et al. Among authors: zhao h. Eur J Med Chem. 2020 Mar 1;189:112075. doi: 10.1016/j.ejmech.2020.112075. Epub 2020 Jan 19. Eur J Med Chem. 2020. PMID: 31986405

6

Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis.

Zhao H, Wang B, Fu L, Li G, Lu H, Liu Y, Sheng L, Li Y, Zhang B, Lu Y, Ma C, Huang H, Zhang D, Lu Y. Zhao H, et al. J Med Chem. 2020 Sep 10;63(17):9316-9339. doi: 10.1021/acs.jmedchem.0c00500. Epub 2020 Aug 5. J Med Chem. 2020. PMID: 32666789

7

Identification of Novel Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents with Excellent Pharmacokinetic Profiles against Drug-Resistant Pathogens.

Wu Y, Wang B, Lu H, Zhao H, Yang B, Li L, Lu Y, Zhang D, Sun N, Huang H. Wu Y, et al. Among authors: zhao h. J Med Chem. 2021 Mar 25;64(6):3234-3248. doi: 10.1021/acs.jmedchem.0c02153. Epub 2021 Mar 11. J Med Chem. 2021. PMID: 33705128

8

Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.

Wang X, Zhao W, Wang B, Ding W, Guo H, Zhao H, Meng J, Liu S, Lu Y, Liu Y, Zhang D. Wang X, et al. Among authors: zhao h, zhao w. Bioorg Chem. 2021 Sep;114:105110. doi: 10.1016/j.bioorg.2021.105110. Epub 2021 Jun 21. Bioorg Chem. 2021. PMID: 34175719

9

Efficient and stereoselective one-pot synthesis of benzo[b]oxazolo[3,4-d][1,4]oxazin-1-ones.

Zhao H, Zhao W, Cheng S, Lu H, Zhang D, Huang H. Zhao H, et al. Among authors: zhao w. RSC Adv. 2020 Jun 23;10(40):24037-24044. doi: 10.1039/d0ra04104a. eCollection 2020 Jun 19. RSC Adv. 2020. PMID: 35517369 Free PMC article.

10

Recent advances in oxazolidinones as antituberculosis agents.

Lu H, Wang H, Zhao H, Zhang D. Lu H, et al. Among authors: zhao h. Future Med Chem. 2022 Aug;14(15):1149-1165. doi: 10.4155/fmc-2022-0079. Epub 2022 Jul 22. Future Med Chem. 2022. PMID: 35866418 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,722 results

Search Page

Filters